BioSpace News Archive

Genetown

Vertex Announces Long-Term Access Agreement in Sweden for Cystic Fibrosis Medicine ORKAMBI® (lumacaftor/ivacaftor)

Vertex Pharmaceuticals Incorporated today announced that ORKAMBI® will be reimbursed in Sweden after concluding the three-party negotiations with TLV and the county councils.

June 18, 2018
·
4 min read
Policy

Hondros College of Nursing Announces Accreditation by Accrediting Bureau of Health Education Schools (ABHES)

Hondros College of Nursing announced that it has received official notification of institutional accreditation by the Accrediting Bureau of Health Education Schools (ABHES), 7777 Leesburg Pike, Suite 314 North, Falls Church, Virginia 22043.

June 18, 2018
·
2 min read
BioMidwest

Health Catalyst Named One of Best Places to Work in IT by Computerworld Magazine

Health Catalyst has been named a 2018 Best Places to Work in IT by IDG’s Computerworld for the second year in a row.

June 18, 2018
·
4 min read
Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000

Leviticus Cardio announces the successful animal implantation of the world’s first Hybrid Wireless Fully Implanted Ventricular Assisted System or “Hybrid FILVAS.”

June 18, 2018
·
3 min read
Drug Development

Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer

Encore investor webcast presentation June 23, 2018

June 18, 2018
·
8 min read
Genetown

Planet Fitness to Present at the Jefferies 2018 Global Consumer Conference

Planet Fitness, Inc. announced that the Company will participate in the Jefferies 2018 Global Consumer Conference.

June 18, 2018
·
1 min read
FDA

FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion

Ortho Dermatologics announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company’s New Drug Application (NDA) for DUOBRII™1 (halobetasol propionate and tazarotene) (IDP-118) lotion in the treatment of plaque psoriasis.

June 18, 2018
·
3 min read
Policy

CAQH Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance

HITRUST Certification validates CAQH commitment to meeting key healthcare regulations and protecting sensitive private healthcare information.

June 18, 2018
·
2 min read
Drug Development

Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus

Clinical Study to Support Application for FDA Approval for Epi-on Corneal Cross-Linking Procedure with New Drug Formulation and Use of Oxygen.

June 18, 2018
·
3 min read
Pharm Country

Blue Earth Diagnostics Announces Fluciclovine F 18 Research Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Blue Earth Diagnostics today announced that presentations related to the clinical use of fluciclovine F 18 injection will be occurring at the SNMMI Annual Meeting

June 18, 2018
·
4 min read